Ann: Cardiex's inHealth Executes Major Co-Marketing Agreement, page-34

Thinking about buying some today.

Just one question though- Does anyone know how well the product line works? If indeed the use of CDX IP and Blumio censor technology mix well to produce a highly effective working product, then the result of yesterday’s announcement would open up the possibility of capturing an enormous sales channel through the mentioned companies. Enough to warrant company insiders to take a big stake of their own in the previous CR. My guess is that the combination works to the extent that insiders would Aquire a significant holding in CDX, as would any entrepreneur who believes in their product/service.

What are people’s thoughts on assuming the technology works well based on the funding provided by management and co? Or are we still awaiting confirmation from trials at Deborah?

Gltah and dyor